Our group studies chemical mechanisms underlying male infertility, prostate cancer, benign prostatic hyperplasia, kidney disease, transgender health, asthma, and infectious diseases. We develop analytical chemistry tools to advance medicine, including biomimetic microfluidic systems for integrated cell culture and small molecule isolation. We collaborate closely with clinicians to better understand how chemical processes are linked to patient symptoms. A related emerging area of research within our group centers on developing culture models and molecular isolation tools to study microbial signaling in the environment and agriculture.